Topcon adquiere VISIA Imaging

Topcon Healthcare y VISIA Imaging tienen una larga historia de colaboración. Su relación comercial comenzó en 1995, cuando iniciaron una exitosa colaboración gracias a la cual han desarrollado conjuntamente instrumentos de última generación como Aladdin, CA-800, CC-100XP, CC-100 o MYAH. 
La adquisición de VISIA permite a Topcon crear sinergias adicionales dentro de la cartera de productos de la empresa, ampliar su oferta de productos, fortalecer la marca Topcon Healthcare y continuar con el crecimiento del negocio. Además, la adquisición proporciona a Topcon Healthcare capacidades adicionales de diseño y desarrollo de productos que acelerarán el desarrollo de los mismos y permitirán a la empresa satisfacer mejor las necesidades del mercado.
De acuerdo con la filosofía de innovación y excelencia, Topcon aprovechará la sinergia de la tecnología y del equipo humano de ambas empresas para seguir diversificando sus productos así como satisfacer y superar las necesidades del mercado.
Ambas compañías ofrecen puntos fuertes en el diseño óptico, la ingeniería mecánica y la fabricación de dispositivos médicos. Con ello, Topcon sigue apostando por potenciar el efecto sinérgico combinado con los valores de fiabilidad y tecnología innovadora que provienen tanto de Topcon como de VISIA.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Tokyo, Japan – July 6^th, 2021 – Topcon Corporation announced that it has acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy.

VISIA Imaging S.r.l (hereinafter “VISIA”), was established in 1993 and specializes in the design, development, and manufacturing of anterior segment (cornea, crystalline lens, etc.) examination hardware and software. This acquisition enhances Topcon’s development and manufacturing capabilities of anterior segment devices and software, which complements the company’s strong portfolio of fundus imaging devices that includes fundus cameras and optical coherence tomography (OCT). The acquisition further reinforces Topcon’s position as a leading ophthalmic diagnostic device manufacturer.

For many years, Topcon has been a distributor of VISIA’s technology including the CC-100 series visual acuity charts (CC-100 series), the CA-800 topographer and corneal analyzer, the MYAH biometer and corneal topographer and the Aladdin biometer.

 “The integration of a Japanese company and an Italian company, both with strengths in optical design, mechanical engineering, and manufacturing of medical devices, will enhance the synergies between the two companies. Both VISIA and Topcon value true reliability and innovative technology, making two companies ideal partners. I am very excited to move forward in our business together to continue producing advanced technology that benefits both patients and eye care professionals.””- commented Fumio Ohue, Managing Executive Officer of Topcon Corporation.

The acquisition of VISIA will enable Topcon to create additional synergies within the company’s product portfolio, expand its product offering, strengthen the Topcon Healthcare brand, and continue to grow the business. Furthermore, the acquisition gives Topcon Healthcare additional product design and development capabilities that will accelerate product development and enable the company to better meet the needs of the market.

“I am so pleased that VISIA Imaging is becoming part of Topcon Healthcare and very excited for the next chapter in our long relationship. VISIA Imaging is focused on development and manufacturing of HW/SW solutions for eye care with high expertise in anterior segment. I am confident to release new beautiful products to support Topcon to become a market leader in myopia management, and to increase Topcon’s presence in cataract surgery with Premium IOL calculation”- said Alessandro Foggi, CEO VISIA Imaging S.r.l

VISIA’s product portfolio helps eye care professionals diagnose and manage a number of eye health conditions including myopia. In recent years, the increase in the number of patients at risk for myopic-related eye diseases has become a global issue, and Topcon is committed to working with eye care professionals to address this eye health problem. By integrating VISIA and its products into the Topcon Healthcare portfolio, the company is better equipped to develop myopia management solutions and strengthen collaborations with companies in the myopia treatment field.

https://www.businesswire.com/news/home/20210714005887/en/Topcon-Healthcare-Acquires-VISIA-Imaging